Plain-English translation of NCT03943316 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Researchers are collecting fluid that builds up in the abdomen of ovarian cancer patients (called ascites) during their surgery. They will use the cancer cells and immune cells from this fluid to test new immunotherapies and create laboratory models of each patient's cancer. This helps scientists develop better treatments tailored to how different patients' cancers behave.
Most ovarian cancer treatments are tested in the laboratory using cancer cells that don't fully represent how real patient cancers work. By studying actual cancer cells from patients, researchers hope to discover new immune-based therapies that are more effective and personalized to individual patients.
You likely qualify if…
You likely don't qualify if…
If you qualify, the study involves providing fluid that your surgeon is already removing during your planned ovarian cancer surgery — no extra procedures are needed. The fluid will be sent to the laboratory where researchers will extract cancer and immune cells to test new immunotherapies and develop personalized cancer models. Your participation ends after the surgery; there are no follow-up visits or long-term commitments required for this laboratory study.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States
Sponsor
New Mexico Cancer Research Alliance
Enrollment target
~100 participants
Started
December 2015
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sarah Adams, MD
UNM Comprehensive Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.